Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Endothelial Protective Properties of Low Molecular Weight Heparin (LMWH) Tinzaparin in Combination with Statin: A Novel Potential Therapeutic Tool in Preventing Cancer Metastasis?

Barry Kevane, MB, Karl Egan, PhD, Seamus Allen, PhD, Patricia Maguire, PhD, Elaine Neary, MD, Áine Lennon, BSc, Fionnuala Ní Áinle, MD PhD

Blood (2016) 128 (22): 881.

https://doi.org/10.1182/blood.V128.22.881.881

Published: 2016

Journal Articles

Association of Comprehensive Lipoprotein Profiling with Coronary Artery Disease in Allogeneic Stem Cell Transplant (Allo-SCT) Survivors

Upneet Chawla, BS, MD, Maureen Sampson, MT, Natasha A Jain, MD, Prathima Anandi, MD, Sawa Ito, MD PhD, Eleftheria Koklanaris, RN, Pawel Muranski, MD, John Barrett, MD, Marcus Y Chen, MD, Alan Remaley, MD PhD, Minoo Battiwalla, MDMS

Blood (2016) 128 (22): 828.

https://doi.org/10.1182/blood.V128.22.828.828

Published: 2016

Journal Articles

Atherosclerotic Cardiovascular Risk in Adult Patients with Hemophilia: What We Can Do to Reduce Risk of Cardiovascular Events? Implementation of 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol in Patients with Hemophilia

Kamila Izabela Cisak, MD, Jianmin Pan, PhD, Shesh Nath Rai, PhD, Patricia Ashby, ARNP, Vivek R. Sharma, MD FACP

Blood (2015) 126 (23): 4687.

https://doi.org/10.1182/blood.V126.23.4687.4687

Published: 2015

Journal Articles

Circulating Lipoprotein Concentrations Correlate with Total but Not Free Heme in Different Sickle Cell Disease Genotypes

Felipe Vendrame, M.Sc., Sara T.O. Saad, MD, PhD, Fernando F Costa, MD, PhD, Kleber Yotsumoto Fertrin, MD, PhD

Blood (2015) 126 (23): 4580.

https://doi.org/10.1182/blood.V126.23.4580.4580

Published: 2015

Journal Articles

Mortality and Morbidity in 15-Year Survivors of Stem Cell Transplants for Haematological Malignancy

Jack Stuart, Richard Szydlo, PhD, Jane F. Apperley, MD, Jeannie Todd, PhD, Nina Salooja, DM, FRCP, FRCPath

Blood (2015) 126 (23): 4348.

https://doi.org/10.1182/blood.V126.23.4348.4348

Published: 2015

Journal Articles

PCYT1A in MYC-Driven Lymphoma: Role on Aberrant Choline Metabolism and Therapeutic Targeting By Berberine

Jie Xiong, PhD, Li Wang, MDPhD, Weili Zhao, MDPhD

Blood (2015) 126 (23): 698.

https://doi.org/10.1182/blood.V126.23.698.698

Published: 2015

Journal Articles

Prospective Analysis Of Plasma Cholesterol and Triglycerides In Patients (pts) With Chronic Phase (CP)-Chronic Myeloid Leukemia (CML) During Treatment With The 2 nd Generation Tyrosine Kinase Inhibitor (TKI) Nilotinib

Delphine Rea, MD, PhD, Tristan Mirault, MD, Jean-Francois Gautier, MD, Francois Guilhot, MD, Emmanuel Messas, MD, Herve Dombret, MD, PhD

Blood (2013) 122 (21): 4042.

https://doi.org/10.1182/blood.V122.21.4042.4042

Published: 2013

Journal Articles

Hypercholesterolemia In Imatinib Intolerant/Resistant CML-CP Patients Treated With Nilotinib: A Retrospective Analysis

Devendra K. Hiwase, MBBS, MD, PhD, FRACP, FRCPA, David T Yeung, BSc, MBBS, FRACP, FRCPA, Lisa Carne, RN, David Ross, Andrew Grigg, MBBS, FRACP, FRCPA, Timothy P. Hughes, MD, MBBS

Blood (2013) 122 (21): 1503.

https://doi.org/10.1182/blood.V122.21.1503.1503

Published: 2013

Journal Articles

Macrocytosis: A Metabolic Marker?

Maeve A O'Reilly, Janas M Harrington, Claire M Buckley, Susan O'Shea, Ivan J Perry, Mary R Cahill

Blood (2013) 122 (21): 4663.

https://doi.org/10.1182/blood.V122.21.4663.4663

Published: 2013

Journal Articles

Patterns Of Non-Hematological Adverse Effects In Patients With Chronic Myeloid Leukemia In Chronic Phase (CML-CP) Treated With Ponatinib – Experience At a Single Institution

Preetesh Jain, MD, DM, PhD, Hagop M. Kantarjian, MD, Carlos Guillermo Romo, MD, Alfonso Quintas-Cardama, MD, Elias Jabbour, MD, Marylou Cardenas-Turanzas, MD, Dr PH, Sherry Pierce, Mary Joy Liboon, Evguenia Gachimova, Tapan M. Kadia, MD, Gautam Borthakur, MD, Farhad Ravandi, MD, Susan O'Brien, MD, Jorge E. Cortes, MD

Blood (2013) 122 (21): 4019.

https://doi.org/10.1182/blood.V122.21.4019.4019

Published: 2013

Journal Articles

The Association Between Atherosclerosis and Venous Thrombosis: Results From the Tromsø Study.

Willem M. Lijfering, PhD, Sigrid Braekkan, Erin Mathiesen Hald, Ellisev B Mathiesen, Suzanne C. Cannegieter, MD, PhD, Frits R. Rosendaal, John-Bjarne Hansen

Blood (2012) 120 (21): 2245.

https://doi.org/10.1182/blood.V120.21.2245.2245

Published: 2012

Journal Articles

Hyperlipidemia After Allogeneic Hematopoietic Stem Cell Transplantation.

Bradley W Blaser, MD, PhD, Haesook Kim, PhD, Jorge Plutzky, MD, Edwin Alyea, III, MD, Vincent Ho, MD, Corey Cutler, MD, MPH, Philippe Armand, MD, PhD, John Koreth, MBBS, DPhil, Joseph H. Antin, MD, Robert Soiffer, MD

Blood (2010) 116 (21): 3457.

https://doi.org/10.1182/blood.V116.21.3457.3457

Published: 2010

Journal Articles

Statins and Venous Thromboembolism In Lung Cancer

Moh'd Khushman, MD, Abdel-ghanie Abu-samra, Shatha Farhan, MD, Gordon Jacobsen, Amr Hanbali, MD, Ding Wang, MD, PhD

Blood (2010) 116 (21): 5122.

https://doi.org/10.1182/blood.V116.21.5122.5122

Published: 2010

Journal Articles

Cholesterol Regulation and Statin Therapy in Patients with Waldenstrom's Macroglobulinemia.

Thea Ioakimidis, MS, Christopher J Patterson, Zachary Hunter, Jacob Soumerai, Robert Manning, Diane L. Warren, Irene Ghobrial, M.D., Patricia Sheehy, NP, Steven Treon, MD, PhD

Blood (2009) 114 (22): 4789.

https://doi.org/10.1182/blood.V114.22.4789.4789

Published: 2009

Journal Articles

Statins Inhibit the Function of Human Antigen-Presenting Cells

Alexander Shimabukuro-Vornhagen, MD, Tanja Liebig, Shahram Zoghi, Clemens M Wendtner, MD, Michael S von Bergwelt-Baildon, MD

Blood (2008) 112 (11): 2560.

https://doi.org/10.1182/blood.V112.11.2560.2560

Published: 2008

Journal Articles

Abnormalities in Lipoprotein Metabolism Provide Insight into Novel Therapeutic Approaches for Waldenstrom’s Macroglobulinemia (WM).

Christopher J. Patterson, BS, Anne Sophie Moreau, MD, Xavier Leleu, MD, Jacob Soumerai, BS, Zachary Hunter, BS, Evdoxia Hatjiharissi, MD, Lian Xu, BS, Steven Treon, MD, PhD

Blood (2006) 108 (11): 4749.

https://doi.org/10.1182/blood.V108.11.4749.4749

Published: 2006

Journal Articles

Antiplatelet Treatment with Aggressive Lipid Lowering Therapy and Reduction of Clinical Event after Ischemic Stroke.

Giorgio Corinaldesi, MD, PhD, Christian Corinaldesi, MD

Blood (2005) 106 (11): 4141.

https://doi.org/10.1182/blood.V106.11.4141.4141

Published: 2005

Journal Articles

Novel Risk Factors for Venous Thromboembolism (VTE): A Population-Based Case-Control Study.

John A. Heit, MD, Sara A. Farmer, BS, Tanya M. Petterson, MS, Kent R. Bailey, PhD, L. Joseph Melton, III, MD, M.P.H.

Blood (2005) 106 (11): 1618.

https://doi.org/10.1182/blood.V106.11.1618.1618

Published: 2005

Journal Articles

Association between Statin and Fibrate Use and Venous Thromboembolism: A Case-Control Study.

Karine Lacut, MD, Gregoire Le Gal, MD, Emmanuel Oger, MD, PhD, Dominique Mottier, MD

Blood (2004) 104 (11): 2594.

https://doi.org/10.1182/blood.V104.11.2594.2594

Published: 2004

Journal Articles

Results of a Phase II Trial of Oral Bexarotene Combined with Interferon Alfa-2b for Patients with Cutaneous T-Cell Lymphoma (CTCL).

David J. Straus, M.D., Madeleine Duvic, M.D., Timothy Kuzel, M.D., Steven Horwitz, M.D., Marie-France Demierre, M.D., Patricia Myskowski, M.D., Kathleen Maignan, B.A., Steven Steckel, Pharm.D.

Blood (2004) 104 (11): 2644.

https://doi.org/10.1182/blood.V104.11.2644.2644

Published: 2004

NARROW

Endothelial Protective Properties of Low Molecular Weight Heparin (LMWH) Tinzaparin in Combination with Statin: A Novel Potential Therapeutic Tool in Preventing Cancer Metastasis?

Association of Comprehensive Lipoprotein Profiling with Coronary Artery Disease in Allogeneic Stem Cell Transplant (Allo-SCT) Survivors

Atherosclerotic Cardiovascular Risk in Adult Patients with Hemophilia: What We Can Do to Reduce Risk of Cardiovascular Events? Implementation of 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol in Patients with Hemophilia

Circulating Lipoprotein Concentrations Correlate with Total but Not Free Heme in Different Sickle Cell Disease Genotypes

Mortality and Morbidity in 15-Year Survivors of Stem Cell Transplants for Haematological Malignancy

PCYT1A in MYC-Driven Lymphoma: Role on Aberrant Choline Metabolism and Therapeutic Targeting By Berberine

Prospective Analysis Of Plasma Cholesterol and Triglycerides In Patients (pts) With Chronic Phase (CP)-Chronic Myeloid Leukemia (CML) During Treatment With The 2 nd Generation Tyrosine Kinase Inhibitor (TKI) Nilotinib

Hypercholesterolemia In Imatinib Intolerant/Resistant CML-CP Patients Treated With Nilotinib: A Retrospective Analysis

Macrocytosis: A Metabolic Marker?

Patterns Of Non-Hematological Adverse Effects In Patients With Chronic Myeloid Leukemia In Chronic Phase (CML-CP) Treated With Ponatinib – Experience At a Single Institution

The Association Between Atherosclerosis and Venous Thrombosis: Results From the Tromsø Study.

Hyperlipidemia After Allogeneic Hematopoietic Stem Cell Transplantation.

Statins and Venous Thromboembolism In Lung Cancer

Cholesterol Regulation and Statin Therapy in Patients with Waldenstrom's Macroglobulinemia.

Statins Inhibit the Function of Human Antigen-Presenting Cells

Abnormalities in Lipoprotein Metabolism Provide Insight into Novel Therapeutic Approaches for Waldenstrom’s Macroglobulinemia (WM).

Antiplatelet Treatment with Aggressive Lipid Lowering Therapy and Reduction of Clinical Event after Ischemic Stroke.

Novel Risk Factors for Venous Thromboembolism (VTE): A Population-Based Case-Control Study.

Association between Statin and Fibrate Use and Venous Thromboembolism: A Case-Control Study.

Results of a Phase II Trial of Oral Bexarotene Combined with Interferon Alfa-2b for Patients with Cutaneous T-Cell Lymphoma (CTCL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only